349 related articles for article (PubMed ID: 26777065)
41. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon.
Streicher KL; Yang ZQ; Draghici S; Ethier SP
Oncogene; 2007 Mar; 26(14):2104-14. PubMed ID: 17001308
[TBL] [Abstract][Full Text] [Related]
42. The expression of squalene epoxidase in human gastric cancer and its clinical significance.
Ma YC; Jin SJ; Gu GJ; Zhao LF; Xu ST
Indian J Pathol Microbiol; 2023; 66(4):799-803. PubMed ID: 38084535
[TBL] [Abstract][Full Text] [Related]
43. High SQLE Expression and Gene Amplification Correlates with Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
Liu Y; Fang L; Liu W
Cancer Manag Res; 2021; 13():4709-4723. PubMed ID: 34163246
[TBL] [Abstract][Full Text] [Related]
44. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
45. Estrogen Abolishes the Repression Role of gga-miR-221-5p Targeting
Zhang DD; Wang DD; Wang Z; Wang YB; Li GX; Sun GR; Tian YD; Han RL; Li ZJ; Jiang RR; Liu XJ; Kang XT; Li H
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120850
[TBL] [Abstract][Full Text] [Related]
46. RECK is not an independent prognostic marker for breast cancer.
Gomes LR; Fujita A; Mott JD; Soares FA; Labriola L; Sogayar MC
BMC Cancer; 2015 Oct; 15():660. PubMed ID: 26449734
[TBL] [Abstract][Full Text] [Related]
47. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
48. Prognostic relevance of gene amplifications and coamplifications in breast cancer.
Al-Kuraya K; Schraml P; Torhorst J; Tapia C; Zaharieva B; Novotny H; Spichtin H; Maurer R; Mirlacher M; Köchli O; Zuber M; Dieterich H; Mross F; Wilber K; Simon R; Sauter G
Cancer Res; 2004 Dec; 64(23):8534-40. PubMed ID: 15574759
[TBL] [Abstract][Full Text] [Related]
49. Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias.
Suspitsin EN; Sokolenko AP; Togo AV; Lazareva YR; Turkevich EA; Matsko DE; Henrich KO; Borresen-Dale AL; Schwab M; Cornelisse CJ; Imyanitov EN
Int J Cancer; 2007 Jan; 120(2):297-302. PubMed ID: 17066426
[TBL] [Abstract][Full Text] [Related]
50. Genome-Scale CRISPR/Cas9 Screening Reveals Squalene Epoxidase as a Susceptibility Factor for Cytotoxicity of Malformin A1.
Koizumi Y; Fukushima J; Kobayashi Y; Kadowaki A; Natsui M; Yamaguchi T; Imai Y; Sugiyama T; Kuba K
Chembiochem; 2019 Jun; 20(12):1563-1568. PubMed ID: 30734978
[TBL] [Abstract][Full Text] [Related]
51. Cholesterol uptake and regulation in high-grade and lethal prostate cancers.
Stopsack KH; Gerke TA; Andrén O; Andersson SO; Giovannucci EL; Mucci LA; Rider JR
Carcinogenesis; 2017 Aug; 38(8):806-811. PubMed ID: 28595267
[TBL] [Abstract][Full Text] [Related]
52.
Zhang R; Deng Y; Lv Q; Xing Q; Pan Y; Liang J; Jiang M; Wei Y; Shi D; Xie B; Yang S
Cell Reprogram; 2020 Feb; 22(1):22-29. PubMed ID: 32011919
[TBL] [Abstract][Full Text] [Related]
53. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T
Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205
[TBL] [Abstract][Full Text] [Related]
54. The MARCH6-SQLE Axis Controls Endothelial Cholesterol Homeostasis and Angiogenic Sprouting.
Tan JME; van der Stoel MM; van den Berg M; van Loon NM; Moeton M; Scholl E; van der Wel NN; Kovačević I; Hordijk PL; Loregger A; Huveneers S; Zelcer N
Cell Rep; 2020 Aug; 32(5):107944. PubMed ID: 32755570
[TBL] [Abstract][Full Text] [Related]
55. Expression and significance of squalene epoxidase in squamous lung cancerous tissues and pericarcinoma tissues.
Zhang HY; Li HM; Yu Z; Yu XY; Guo K
Thorac Cancer; 2014 Jul; 5(4):275-80. PubMed ID: 26767013
[TBL] [Abstract][Full Text] [Related]
56. Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis.
Brandt B; Vogt U; Schlotter CM; Jackisch C; Werkmeister R; Thomas M; von Eiff M; Bosse U; Assmann G; Zänker KS
Gene; 1995 Jun; 159(1):35-42. PubMed ID: 7607571
[TBL] [Abstract][Full Text] [Related]
57. On statistical relationship between ADRA2A expression and the risk of breast cancer relapse.
Shkurnikov MY; Galatenko VV; Lebedev AE; Podol'skii VE; Tonevitskii EA; Mal'tseva DV
Bull Exp Biol Med; 2014 Aug; 157(4):454-8. PubMed ID: 25110082
[TBL] [Abstract][Full Text] [Related]
58. Amplification of HER-2(erbB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients.
Imyanitov EN; Chernitsa OI; Serova OM; Nikoforova IF; Pluzhnikova GF; Knyazev PG
Neoplasma; 1993; 40(1):35-9. PubMed ID: 7688867
[TBL] [Abstract][Full Text] [Related]
59. p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth.
Sun H; Li L; Li W; Yang F; Zhang Z; Liu Z; Du W
EMBO Rep; 2021 Oct; 22(10):e52537. PubMed ID: 34459531
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
